Chevy Chase Trust Holdings, Inc. Abbott Laboratories Transaction History
Chevy Chase Trust Holdings, Inc.
- $32.3 Billion
- Q3 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 967,226 shares of ABT stock, worth $111 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
967,226
Previous 984,178
1.72%
Holding current value
$111 Million
Previous $102 Million
7.83%
% of portfolio
0.34%
Previous 0.33%
Shares
30 transactions
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.31BCall Options Held
8.74MPut Options Held
7.89M-
Vanguard Group Inc Valley Forge, PA168MShares$19.3 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.83 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.56 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.13 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $201B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...